治疗药物监测 (Therapeutic Drug Monitoring)
June 2025 - Volume 47 - Issue 3 
https://journals.lww.com/drug-monitoring/pages/currenttoc.aspx

大查房（Grand Round）
1. 哺乳期女性使用拉莫三嗪：药物向母乳的转移及婴儿暴露情况（Lamotrigine Use in Lactating Women: Passage Into Breast Milk and Infant Exposure）。
den Besten-Bertholee, Daphne; Wegner, Ilse; Touw, Daan J.; More
Therapeutic Drug Monitoring. 47(3):317-319, June 2025.
2. 阿贝西利对利伐沙班的显著影响（Significant Influence of Abemaciclib on Rivaroxaban）。
He, Xiaoshuang; Ding, Yongjie; Fang, Jie; More
Therapeutic Drug Monitoring. 47(3):320-322, June 2025.

病例报告（Case Report）
3. 甲状腺癌伴手足综合征患者的血清仑伐替尼浓度监测（Serum Lenvatinib Concentration Monitoring in a Patient With Thyroid Cancer Exhibiting Hand-Foot Syndrome）。
Watanabe, Yusuke; Doki, Kosuke; Sekine, Ikuo; More
Therapeutic Drug Monitoring. 47(3):323-325, June 2025.
4. 胰腺胰岛移植受者合并SARS-CoV-2肺炎中抗病毒药物与他克莫司的延迟药物相互作用（Delayed Drug–Drug Interaction Between Antiviral Drugs and Tacrolimus in a Pancreatic Islet Transplant Recipient With SARS-CoV-2 Pneumonia）。
Sabo, Amelia-Naomi; Cunat, Sibylle; Kemmel, Véronique
Therapeutic Drug Monitoring. 47(3):326-329, June 2025.

原创文章（Original Article）
5. 基因多态性在肾移植患者泊沙康唑与他克莫司药物相互作用中的重要作用（Gene Polymorphisms Play an Important Role in the Drug Interaction Between Posaconazole and Tacrolimus in Renal Transplant Patients）。
Hu, Nan; Guan, Mengmeng; Gu, Bin; More
Therapeutic Drug Monitoring. 47(3):330-336, June 2025.
6. 静脉注射托珠单抗的精准剂量：基于药代动力学模型的类风湿关节炎患者减量策略开发（Precision Dosing of Intravenous Tocilizumab: Development of Pharmacokinetic Model–Derived Tapering Strategies for Patients With Rheumatoid Arthritis）。
Hooijberg, Femke; van den Berg, Stefan P. H.; Layegh, Zohra; More
Therapeutic Drug Monitoring. 47(3):337-345, June 2025.
7. AFIAS-10床旁检测与酶联免疫吸附法在英夫利昔单抗及阿达木单抗治疗药物监测中的准确性与临床效用评估（Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic
Drug Monitoring of Infliximab and Adalimumab）。
Iniesta-Navalón, Carles; Ríos-Saorín, Manuel; Añez-Castaño, Rebeca; More
Therapeutic Drug Monitoring. 47(3):346-352, June 2025.
8. 急诊科阿米卡星剂量优化：基于群体药代动力学的模拟研究（Dose Optimization of Amikacin in the Emergency Department: A Population Pharmacokinetics Simulation Study）。
Dia, Nada; De Winter, Sabrina; Gijsen, Matthias; More
Therapeutic Drug Monitoring. 47(3):353-362, June 2025.
9. 液相色谱-串联质谱法用于儿科及青少年患者血浆中达巴万星的治疗药物监测（Liquid Chromatography–Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Plasma of Pediatric and Young Adult Patients）。
Cafaro, Alessia; Mariani, Marcello; Pigliasco, Federica; More
Therapeutic Drug Monitoring. 47(3):363-369, June 2025.
10. 氨苄西林高效液相色谱-紫外光谱法的开发与验证及其在重症患者常规治疗药物监测中的应用（Development and Validation of a High-Performance Liquid Chromatography–Ultraviolet Spectrometry Method for Ampicillin and Its Application in
Routine Therapeutic Drug Monitoring of Intensive Care Patients）。
Morath, Benedict; Schultes, Linda; Frey, Otto Roman; More
Therapeutic Drug Monitoring. 47(3):370-377, June 2025.
11. 基于机制的伏立康唑药代/药效模型预测侵袭性曲霉病成人患者的临床结局（Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Voriconazole for Predicting the Clinical Outcomes of Adult Patients With Invasive Aspergillosis）。
Duangpraphat, Monchai; Wilson, Richard C.; Rawson, Timothy M.; More
Therapeutic Drug Monitoring. 47(3):378-384, June 2025.
12. 增强肾清除与发热性中性粒细胞减少对替考拉宁初始谷浓度及清除率的影响（Effect of Augmented Renal Clearance and Febrile Neutropenia on Initial Trough Level and Clearance of Teicoplanin）。
Kondo, Nozomi; Tanaka, Ryota; Tatsuta, Ryosuke; More
Therapeutic Drug Monitoring. 47(3):385-392, June 2025.
13. 先天性巨细胞病毒感染婴儿中缬更昔洛韦的药代与药效学评估（Pharmacokinetic and Pharmacodynamic Assessment of Valganciclovir in Infants With Congenital Cytomegalovirus Infection）。
Itohara, Kotaro; Yamamoto, Kazuhiro; Fujinaka, Shunsuke; More
Therapeutic Drug Monitoring. 47(3):393-399, June 2025.
14. 日本晚期肾细胞癌患者血浆卡博替尼浓度与治疗反应及不良事件的关联性（Association of Plasma Cabozantinib Concentration With Treatment Response and Adverse Events in Japanese Patients With Advanced Renal Cell Carcinoma）。
Maruyama, Shinichi; Kobayashi, Hiroaki; Hiraga, Tatsuru; More
Therapeutic Drug Monitoring. 47(3):400-406, June 2025.
15. 拉科酰胺在日本癫痫患者中的药代动力学与保留率：年龄、合并用药及CYP2C19多态性影响的回顾性研究（Lacosamide Pharmacokinetics and Retention in Japanese Patients With Epilepsy: A Retrospective Study on the Influence of Age,
Comedications, and Cytochrome P450 2C19 Polymorphism）。
Yamamoto, Yoshiaki; Shiratani, Yuka; Nishida, Takuji; More
Therapeutic Drug Monitoring. 47(3):407-412, June 2025.
16. 提升母体与新生儿毛发中丁丙诺啡及其代谢物检测与定量的方法（An Approach for Improving the Detection and Quantitation of Buprenorphine and Its Metabolites in Maternal and Neonatal Hair）。
Alshogran, Osama Y.; Zhao, Wenchen; Krans, Elizabeth E.; More
Therapeutic Drug Monitoring. 47(3):413-420, June 2025.

短讯（Short Communication）
17. 儿科造血干细胞移植受者中评估白消安暴露的不同方法比较（Examining Different Methods to Assess Busulfan Exposure in Pediatric Hematopoietic Stem Cell Transplant Recipients）。
Thompson, Maxwell; Staatz, Christine E.; Fraser, Christopher J.; More
Therapeutic Drug Monitoring. 47(3):421-426, June 2025.
18. 超滤法与平衡透析法测定血浆中未结合头孢曲松浓度的对比研究（Unbound Ceftriaxone Concentrations in Plasma Measured Using Ultrafiltration Versus Equilibrium Dialysis）。
Gijsen, Matthias; Vanneste, Dorian; Annaert, Pieter; More
Therapeutic Drug Monitoring. 47(3):427-432, June 2025.
19. 英夫利昔单抗与阿达木单抗治疗药物监测两种商业化检测方法的比较分析（Comparative Analysis of 2 Commercially Available Assays for Therapeutic Drug Monitoring of Infliximab and Adalimumab）。
López Pérez, Juan; Inda-Landaluce, Mercedes; Nocito-Colón, Mercedes; More
Therapeutic Drug Monitoring. 47(3):433-437, June 2025.
20. 硝苯地平可能抑制氯氮平代谢：来自5例患者的观察（2例美国双盲研究，3例德国治疗药物监测研究）（Nifedipine May Be an Inhibitor of Clozapine Metabolism as Seen in 5 Patients: 2 From a US Double-Blind Study and 3 From a German
Therapeutic Drug Monitoring Study）
Schoretsanitis, Georgios; Haen, Ekkehard; Verdoux, Hélène; More
Therapeutic Drug Monitoring. 47(3):438-441, June 2025.